Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Erickson

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Journal of Child and Adolescent Psychopharmacology|February 6, 2025
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content ValidityLindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxietyTori L Schaefer, Matthew H Davenport, Lindsay M Grainger, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Aberrant Neural Entrainment to Word-Level Speech Patterns in Fragile X Syndrome: Evidence for a Statistical Learning DeficitLaura Batterink, Yanchen Liu, Grace Westerkamp, et al.
Journal of Neurodevelopmental Disorders|June 15, 2024
Developmental milestones and daily living skills in individuals with Angelman syndromeAnjali Sadhwani, Sonya Powers, Anne Wheeler, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Auditory steady-state response deficits in Fragile X Syndrome implicate deficits in stimulus representation maintenance and GABAergic modulationJordan E Norris, Lisa A De Stefano, Walker S McKinney, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 2022
A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorderChristopher J McDougle, Robyn P Thom, Caitlin T Ravichandran, et al.
Journal of Autism and Developmental Disorders|November 23, 2024
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change ThresholdsMeredith A Nelson, Lauren M Schmitt, Paul S Horn, et al.
Journal of Autism and Developmental Disorders|August 31, 2019
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional AnalysisEleanor M Eckert, Kelli C Dominick, Ernest V Pedapati, et al.
Journal of Autism and Developmental Disorders|May 14, 2024
Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum DisorderElizabeth Blank, Donald L Gilbert, Steve W Wu, et al.
Scientific Reports|March 30, 2023
Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorderLauren M Schmitt, Elizabeth G Smith, Ernest V Pedapati, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Journal of Child and Adolescent Psychopharmacology|February 6, 2025
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content ValidityLindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, et al.
Journal of Neurodevelopmental Disorders|June 16, 2017
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxietyTori L Schaefer, Matthew H Davenport, Lindsay M Grainger, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Aberrant Neural Entrainment to Word-Level Speech Patterns in Fragile X Syndrome: Evidence for a Statistical Learning DeficitLaura Batterink, Yanchen Liu, Grace Westerkamp, et al.
Journal of Neurodevelopmental Disorders|June 15, 2024
Developmental milestones and daily living skills in individuals with Angelman syndromeAnjali Sadhwani, Sonya Powers, Anne Wheeler, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Auditory steady-state response deficits in Fragile X Syndrome implicate deficits in stimulus representation maintenance and GABAergic modulationJordan E Norris, Lisa A De Stefano, Walker S McKinney, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 2022
A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorderChristopher J McDougle, Robyn P Thom, Caitlin T Ravichandran, et al.
Journal of Autism and Developmental Disorders|November 23, 2024
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change ThresholdsMeredith A Nelson, Lauren M Schmitt, Paul S Horn, et al.
Journal of Autism and Developmental Disorders|August 31, 2019
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional AnalysisEleanor M Eckert, Kelli C Dominick, Ernest V Pedapati, et al.
Journal of Autism and Developmental Disorders|May 14, 2024
Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum DisorderElizabeth Blank, Donald L Gilbert, Steve W Wu, et al.
Scientific Reports|March 30, 2023
Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorderLauren M Schmitt, Elizabeth G Smith, Ernest V Pedapati, et al.
Pageof 16